Page 3 - Clin Hypertens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Depression & Medication Adherence in Coronary Heart Disease

Examining the mediating role of social support and self-efficacy between depression and medication adherence in older patients with coronary heart disease.

New yorkUnited statesKhorasane janubiSwitzerland generalColl cardiolClin hypertensJ clin pharmacolDevelopment planAmerican association for thoracic surgerySociety for cardiovascular angiographyPreventive cardiovascular nurses associationNurs health sciHealth educ behavPrentice hall incSociety of thoracic surgeonsHealth psychol

Sobi and Selecta Biosciences announce completion of enrolment in DISSOLVE Phase 3 study evaluating SEL-212 for chronic refractory gout

/PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) and Selecta Biosciences, Inc. (NASDAQ: SELB), today announced the completion of.

United statesCarsten brunnClin hypertensBrittany leighBruce mackleSelecta biosciencesSelecta immGuido oelkersLifesci advisorsLifesci communicationsSelecta biosciences incSobi investor relations teamChief executive officerRandomized double blindPlacebo controlled studyGout refractory

Swedish Orphan Biovitrum AB: Sobi and Selecta Biosciences announce completion of enrolment in DISSOLVE Phase 3 study evaluating SEL-212 for chronic refractory gout

STOCKHOLM, Dec. 1, 2021 /PRNewswire/ Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) and Selecta Biosciences, Inc. (NASDAQ: SELB), today announced the completion of enrolment for DISSOLVE

United statesCarsten brunnClin hypertensBrittany leighBruce mackleSelecta biosciencesSelecta immGuido oelkersLifesci advisorsLifesci communicationsSelecta biosciences incSobi investor relations teamChief executive officerRandomized double blindPlacebo controlled studyGout refractory

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United kingdomSri lankaColl cardiolJ clin hypertensWright jrCommittee for medicinal products humanDrug administrationInternational society of hypertensionLancet public healthNational heart foundation of australiaGlobal burdenDisease studyHeart foundationMethods med resMedicinal productsDes devel ther

Arterial hypertension

Arterial hypertension
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesSri lankaUnited kingdomJapan generalCity ofJammu and kashmirSouth koreaNat genetColl cardiolMaurerg serruysWright jrJ clin hypertensEuropean society of hypertensionAmerican heart associationWorld health assemblyHealth promotion series